Product image of Moxogamma (Moxonidine) supplied by GNH India

Moxogamma

Active Ingredient:
Moxonidine
Origin:
EU

Moxogamma (Moxonidine)

Moxonidine, the active ingredient in Moxogamma, is a centrally acting antihypertensive (imidazoline I1 receptor agonist) presented as a tablet for oral use. It reduces elevated blood pressure by decreasing sympathetic nervous system activity and is indicated for the management of hypertension in adult patients.

GNH India supplies Moxogamma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. All batches are manufactured under EU GMP guidelines and undergo rigorous quality testing before distribution. The company maintains traceability and provides full documentation to meet import and regulatory requirements.

Manufacturer / TM Owner

Wörwag Pharma Gmbh & Co. Kg

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Moxogamma acts on the central imidazoline I1 receptors to lower blood pressure in patients with hypertension.
  • Hypertension: Lowers systolic and diastolic blood pressure, helping patients achieve target blood pressure levels.

How It Works

  • Moxonidine selectively activates central imidazoline I1 receptors, which reduces sympathetic outflow from the brainstem. This leads to decreased peripheral vascular resistance, lower heart rate, and ultimately a reduction in arterial blood pressure without significant direct cardiac effects.

Side Effects

Moxogamma may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects

  • Dry mouth: sensation of reduced salivation.
  • Fatigue: feeling of tiredness or lack of energy.
  • Dizziness: light‑headedness, especially when standing quickly.
  • Headache: mild to moderate head pain.
  • Nausea: upset stomach, sometimes with mild vomiting.
  • Constipation: reduced bowel movements.

Serious or Rare Side Effects

  • Severe hypotension: marked drop in blood pressure requiring medical attention.
  • Bradycardia: unusually slow heart rate.
  • Allergic reactions: rash, itching, swelling, or difficulty breathing.
  • Hepatic dysfunction: abnormal liver enzyme elevations.
  • Syncope: sudden fainting episodes.
  • Electrolyte disturbances: abnormal potassium or sodium levels.

Precautions & Warnings

  • Before initiating therapy with Moxogamma, consider the following safety measures.
  • Monitor blood pressure regularly: ensure target levels are reached without excessive drop.
  • Adjust dose in renal impairment: reduced clearance may require lower dosing.
  • Caution in elderly patients: increased sensitivity to hypotensive effects.
  • Avoid abrupt discontinuation: tapering may be needed to prevent rebound hypertension.
  • Review concomitant antihypertensives: assess for additive blood‑pressure lowering.
  • Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Avoid Interactions

Moxogamma can interact with other medicines, altering its efficacy or safety.

Major Interactions (Avoid)

  • Other centrally acting antihypertensives (e.g., clonidine, rilmenidine): additive hypotensive effect.
  • Potent CYP2D6 inhibitors (e.g., fluoxetine, paroxetine): may increase plasma concentrations.

Moderate Interactions (Monitor Closely)

  • Diuretics: enhanced antihypertensive response, monitor electrolytes.
  • ACE inhibitors or ARBs: additive blood‑pressure reduction, watch for hypotension.
  • NSAIDs: may blunt antihypertensive effect, assess blood‑pressure control.
  • Beta‑blockers: combined effect on heart rate, monitor for bradycardia.

Frequently Asked Questions

Moxogamma contains the active ingredient moxonidine and is used to treat hypertension. By lowering elevated blood pressure, it helps reduce the risk of cardiovascular complications in adult patients diagnosed with high blood pressure.

Moxonidine selectively stimulates central imidazoline I1 receptors, which diminishes sympathetic nervous system activity. This reduction leads to decreased peripheral vascular resistance and lower arterial pressure, providing an antihypertensive effect without strong direct cardiac stimulation.

The appropriate dose of Moxogamma is determined by the prescribing healthcare professional based on the individual’s blood‑pressure profile, age, renal function and concomitant therapies. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

Safety data for moxonidine in pregnancy and lactation are limited. It should only be used if the potential benefit justifies the potential risk to the fetus or infant, and the decision must be made by a qualified healthcare provider.

To request Moxogamma, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Moxogamma belongs to the centrally acting imidazoline I1 receptor agonist class, which differs from ACE inhibitors, ARBs, calcium‑channel blockers and diuretics. Its mechanism reduces sympathetic outflow, offering an alternative for patients who need additional blood‑pressure control or who experience side effects with other classes.

Moxogamma should be stored at room temperature, below 25 °C, in its original packaging. Keep the product away from moisture, direct sunlight and excessive heat to maintain its stability and potency.

Moxogamma is taken orally, typically as a tablet, with or without food as directed by the prescriber. Patients should swallow the tablet whole with a glass of water and follow the dosing schedule provided by their healthcare professional.

Serious risks include severe hypotension, bradycardia, allergic reactions such as rash or anaphylaxis, and rare cases of hepatic dysfunction. Patients should seek immediate medical attention if they experience fainting, rapid heartbeat, difficulty breathing, or signs of liver injury.

Moxogamma is contraindicated in patients with known hypersensitivity to moxonidine or any excipients in the formulation. Caution is advised for individuals with severe renal impairment, uncontrolled heart failure, or those taking other central antihypertensives without medical supervision.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Moxonidine

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT